Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 19,403Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Dr. Reddy's Laboratories

02 1Olpha

03 3Acino Pharma (Pty) Ltd

04 3Assia Chemical Industries Ltd

05 5Exelixis

06 3Intas Pharmaceuticals

07 24Ipsen

08 2TMC Pharma Services Ltd.,

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Cabozantinib

Brand Name :

Dosage Form : Oral Solid Dosage Form

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Dr Reddy Company Banner

02

arrow
Peptide-Based Therapeutics Summit
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.

Regulatory Info : Dossier Readiness: Q1 2026

Registration Country : Latvia

Cabozantinib

Brand Name :

Dosage Form : Tablet

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Readiness: Q1 2026

Registration Country : Latvia

Olpha

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Cabozantinib

Brand Name :

Dosage Form : Oral Solid Dosage Form

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Dr Reddy Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Cabozantinib

Brand Name :

Dosage Form : Oral Solid Dosage Form

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Dr Reddy Company Banner

05

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

CABOZANTINIB

Brand Name : CABOZANTINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number : 215942

Regulatory Info :

Registration Country : USA

blank

06

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

CABOZANTINIB

Brand Name : CABOZANTINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 215942

Regulatory Info :

Registration Country : USA

blank

07

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

CABOZANTINIB

Brand Name : CABOZANTINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number : 215942

Regulatory Info :

Registration Country : USA

blank

08

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

CABOZANTINIB S-MALATE

Brand Name : COMETRIQ

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2012-11-29

Application Number : 203756

Regulatory Info : RX

Registration Country : USA

blank

09

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

CABOZANTINIB S-MALATE

Brand Name : COMETRIQ

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 80MG BASE

Packaging :

Approval Date : 2012-11-29

Application Number : 203756

Regulatory Info : RX

Registration Country : USA

blank

10

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

CABOZANTINIB S-MALATE

Brand Name : CABOMETYX

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2016-04-25

Application Number : 208692

Regulatory Info : RX

Registration Country : USA

blank

11

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

CABOZANTINIB S-MALATE

Brand Name : CABOMETYX

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 40MG BASE

Packaging :

Approval Date : 2016-04-25

Application Number : 208692

Regulatory Info : RX

Registration Country : USA

blank

12

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

CABOZANTINIB S-MALATE

Brand Name : CABOMETYX

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 60MG BASE

Packaging :

Approval Date : 2016-04-25

Application Number : 208692

Regulatory Info : RX

Registration Country : USA

blank

13

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

14

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

15

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

16

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name : Cabometyx

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 20 mg

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

17

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name : Cabometyx

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 40 mg

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

18

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name : Cabometyx

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 60 mg

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

19

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name : Cometriq

Dosage Form :

Dosage Strength :

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

20

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name : Cometriq

Dosage Form :

Dosage Strength :

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

21

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name : Cometriq

Dosage Form : Capsule, hard

Dosage Strength : 20 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

22

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name : Cabometyx

Dosage Form : Film-Coated Tablets

Dosage Strength : 20mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

23

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name : Cabometyx

Dosage Form : Film-Coated Tablets

Dosage Strength : 40mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

24

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name : Cabometyx

Dosage Form : Film-Coated Tablets

Dosage Strength : 60mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

25

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

CABOZANTINIB (CABOZANTINIB MALATE)

Brand Name : CABOMETYX

Dosage Form : TABLET

Dosage Strength : 60MG

Packaging : 30

Approval Date :

Application Number : 2480840

Regulatory Info : Prescription

Registration Country : Canada

blank

26

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

CABOZANTINIB (CABOZANTINIB MALATE)

Brand Name : CABOMETYX

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 30

Approval Date :

Application Number : 2480824

Regulatory Info : Prescription

Registration Country : Canada

blank

27

Peptide-Based Therapeutics Summit
Not Confirmed
arrow
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

CABOZANTINIB (CABOZANTINIB MALATE)

Brand Name : CABOMETYX

Dosage Form : TABLET

Dosage Strength : 40MG

Packaging : 30

Approval Date :

Application Number : 2480832

Regulatory Info : Prescription

Registration Country : Canada

blank

28

TMC Pharma Services Ltd.,

Country
Peptide-Based Therapeutics Summit
Not Confirmed
arrow

TMC Pharma Services Ltd.,

Country
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

kabozantinib S-malate

Brand Name : Cometriq

Dosage Form : HARD CAPSULES

Dosage Strength : 20 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

29

TMC Pharma Services Ltd.,

Country
Peptide-Based Therapeutics Summit
Not Confirmed
arrow

TMC Pharma Services Ltd.,

Country
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

kabozantinib S-malate

Brand Name : Cometriq

Dosage Form : HARD CAPSULES

Dosage Strength : 20 MG + 80 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

30

Acino Pharma (Pty) Ltd

Country
Peptide-Based Therapeutics Summit
Not Confirmed
arrow

Acino Pharma (Pty) Ltd

Country
arrow
Peptide-Based Therapeutics Summit
Not Confirmed

Cabozantinib

Brand Name : CABOMETYX 20 MG

Dosage Form : FCT

Dosage Strength : 20mg

Packaging : 30X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank